Search clinical trials for: Benign Prostatic Hyperplasia

Total 7824 results

Kocatepe University

Completed

The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil

Benign Prostatic Hyperplasia | Choroid Disease | Pupil Anomaly
Sophiris Bio Corp

Completed

Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH (PLUS-1)

Benign Prostatic Hyperplasia

United States, Australia, Canada, Russian Federation, Ukraine, New Zealand
Mansoura University

Completed

A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy

Benign Prostate Hyperplasia

Egypt
Yuyu Pharma, Inc.

Completed

A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects

Benign Prostate Hyperplasia
First Affiliated Hospital, Sun Yat-Sen University

Unknown

Effect of Enhanced External Counterpulsation on Lower Urinary Tract Symptoms (EECPLUTS)

Lower Urinary Tract Symptoms

China
Xiangfu Zhou

Unknown

The Influence of Benign Prostatic Hyperplasia on Bladder Function

Prostatic Hyperplasia

China
Astellas Pharma Europe B.V.

Completed

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms (Neptune)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
Nymox Corporation

Completed

Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018

Benign Prostatic Hyperplasia (BPH)

United States
JW Pharmaceutical

Completed

Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia | Nocturia

Korea, Republic of
Nymox Corporation

Completed

Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)

Benign Prostatic Hyperplasia | BPH | LUTS | Lower Urinary Tract Symptoms (LUTS)

United States
GlaxoSmithKline

Completed

Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment

Prostatic Hyperplasia

United States, Netherlands, Spain, Taiwan, Bulgaria, Estonia, Hungary, Italy, Belgium, Thailand, Israel, Germany, Canada, Korea, Republic of, Norway, Finland, Russian Federation, Romania, Brazil, France, Slovakia, Philippines, South... and more
IRCCS Policlinico S. Matteo

Completed

Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia (Odyliresin)

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy With Outflow Obstruction

Italy
Beni-Suef University

Completed

Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients.

Benign Prostatic Hyperplasia

Egypt
Yonsei University

Completed

Changes of the Hemodynamic Profiles on Bio Reactance Technique During TURP in Elderly Patients

Benign Prostate Hyperplasia
GlaxoSmithKline

Completed

Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer

Benign Prostatic Hyperplasia | Prostate Cancer

Netherlands
Health Ever Bio-Tech Co., Ltd.

Completed

Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-TWN-c)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Taiwan
GlaxoSmithKline

Completed

WEUSKOP5723: Prostate Cancer Study

Prostatic Hyperplasia
Maastricht University Medical Center
Yamanouchi

Completed

Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Netherlands
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

Benign Prostatic Hyperplasia
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

Benign Prostate Hyperplasia

Korea, Republic of
University of Missouri-Columbia
National Library of Medicine (NLM)

Completed

Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow

Depression | HIV Infections | Hypertension | Obesity | Diabetes Mellitus | Back Pain | Urinary Incontinence | Irritable Bowel Syndrome | Insomnia | Asthma | Anxiety | Sinusitis | Shoulder Pain | Allergic Rhinitis | Urinary Tract Infection | Vaginitis | Bursitis | Hyperlipidemia | Esophageal Reflux | Benign Prostatic Hypertrophy | Osteoporosis... and other conditions

United States
Pierre Fabre Medicament

Completed

PERmixon® in LUTS Evaluation Study (PERLES) (PERLES)

Benign Prostatic Hyperplasia (BPH)

France, Italy, Germany, Spain, Czech Republic
Central Clinical Hospital w/Outpatient Health Center...
I.M. Sechenov First Moscow State Medical University

Unknown

Effectiveness and Safety of Adipose-derived Regenerative Cells for Reduction of Risk of Bladder Neck Contracture

Benign Prostatic Hyperplasia | Bladder Outlet Obstruction | Urinary Bladder Neck Obstruction | Bladder Neck Obstruction

Russian Federation
IlDong Pharmaceutical Co Ltd

Unknown

The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction

Benign Prostatic Hyperplasia | Erectile Dysfunction

Korea, Republic of
IlDong Pharmaceutical Co Ltd

Unknown

Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia

Benign Prostate Hyperplasia

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin

Overactive Bladder | Benign Prostatic Hyperplasia | LUTS

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers

Overactive Bladder | Benign Prostatic Hyperplasia | LUTS
Jeil Pharmaceutical Co., Ltd.

Completed

The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.

Overactive Bladder | Benign Prostatic Hyperplasia | LUTS(Lower Urinary Tract Symptoms)
Golden Biotechnology Corporation

Completed

Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Taiwan
Shiraz University of Medical Sciences

Completed

Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate (TURP)

Benign Prostate Hyperplasia

Iran, Islamic Republic of
Saskatchewan Health Authority - Regina Area

Completed

Prostatic Artery Embolization for Benign Prostatic Hyperplasia

Benign Prostate Hyperplasia

Canada
Mansoura University

Unknown

Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency

Benign Prostatic Hyperplasia

Egypt
Astellas Pharma Taiwan, Inc.

Completed

Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms

Overactive Bladder | Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia (BPH)

Taiwan
Takeda

Withdrawn

Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction

Benign Prostatic Hyperplasia | Erectile Dysfunction

Mexico
GL Pharm Tech Corporation

Completed

Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS (GL2702)

Benign Prostatic Hyperplasia

Korea, Republic of
Istanbul University

Completed

Bipolar Versus Monopolar Resection of Benign Prostate Hyperplasia

Acute Hyponatremia

Turkey
Daniel Stephan Engeler

Completed

A Prospective Investigation Using the Expired Breath Ethanol Test

Benign Prostatic Hyperplasia (BPH)

Switzerland
Assistance Publique - Hôpitaux de Paris
Merck Sharp & Dohme LLC

Completed

Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration (ERTAPRO)

Benign Prostatic Hyperplasia (BPH) Requiring Surgical Resection

France
Chong Kun Dang Pharmaceutical

Completed

Study to Compare the Safety and Pharmacokinetics of CKD-397 (CKD-397)

Benign Prostatic Hyperplasia

Korea, Republic of
Brigham and Women's Hospital
CVS Caremark

Completed

Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices (REMIND)

Depression | Epilepsy | Cardiovascular Disease | Diabetes | Breast Cancer | Parkinson's Disease | Mental Health Disorder | Prostatic Hypertrophy, Benign

United States
Astellas Pharma Europe B.V.

Completed

EC905 Pharmacokinetic Profile Study

Healthy | Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Phase 1

Netherlands
Astellas Pharma Inc
Astellas Pharma Taiwan, Inc.

Completed

A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation

Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)

Taiwan
Northwestern University
GlaxoSmithKline

Terminated

A Clinical Trial Comparing Laser TURP With and Without Dutasteride.

Benign Prostatic Hyperplasia
American Medical Systems

Completed

A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization (PVP)

Benign Prostatic Hyperplasia

United States
Astellas Pharma Inc

Completed

A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome

Irritable Bowel Syndrome

Japan
Kaiser Permanente

Completed

A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Medifocus, Inc.

Unknown

Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)

Benign Prostate Hyperplasia

United States
University Hospital, Tours

Completed

Assessing the Impact of the PVP With Greenlight Laser Using Prostatic MRI and Contrast-enhanced Ultrasound (PROPIL)

Prostatic Hypertrophy, Benign

France
HistoSonics, Inc.

Withdrawn

Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)

Benign Prostatic Hyperplasia (BPH)
University Hospital, Rouen

Terminated

Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benign Prostatic Hyperplasia Refractory to Medical Treatment. (Prost-EMBOL)

Benign Prostatic Hyperplasia

France

Search clinical trials for: Benign Prostatic Hyperplasia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations